II
PCVX icon

Ishara Investments’s Vaxcyte PCVX Stock Holding History

Ishara Investments’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.77M Buy
82,000
+24,600
+43% +$1.34M 3.5% 10
2026
Q1 		$3.34M Buy
57,400
+7,400
+15% +$402K 3.16% 11
2025
Q4 		$2.31M Buy
+50,000
New +$2.24M 2.64% 12

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Ishara Investments's PCVX Position: Q2 2026 in Review

Ishara Investments increased its Vaxcyte (PCVX) stake by 43% in Q2 2026, buying an estimated $1.34M and bringing the position to 82,000 shares worth $4.77M. The position accounts for 3.5% of the portfolio, ranked #10.

Ishara Investments first reported a position in PCVX in Q4 2025 and has held it in 3 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Ishara Investments held 82,000 shares of Vaxcyte worth $4.77M as of Q2 2026.
  • Ishara Investments bought 24,600 Vaxcyte shares in Q2 2026, an estimated $1.34M.
  • Vaxcyte made up 3.5% of Ishara Investments's portfolio in Q2 2026, its #10 holding.
  • Ishara Investments first reported a position in Vaxcyte in Q4 2025 and has held it in 3 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.